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Abstract
Introduction: The utility of T-cell based interferon-gamma release assays for the diagnosis of latent tuberculosis infection
remains unclear in settings with a high burden of tuberculosis.
Objectives: To determine risk factors associated with positive QuantiFERON-TB Gold In-Tube (QFT-GIT) and tuberculin skin
test (TST) results and the level of agreement between the tests; to explore the hypotheses that positivity in QFT-GIT is more
related to recent infection and less affected by HIV than the TST.
Methods: Adult household contacts of tuberculosis patients were invited to participate in a cross-sectional study across 24
communities in Zambia and South Africa. HIV, QFT-GIT and TST tests were done. A questionnaire was used to assess risk
factors.
Results: A total of 2,220 contacts were seen. 1,803 individuals had interpretable results for both tests, 1,147 (63.6%) were
QFT-GIT positive while 725 (40.2%) were TST positive. Agreement between the tests was low (kappa = 0.24). QFT-GIT and
TST results were associated with increasing age (adjusted OR [aOR] for each 10 year increase for QFT-GIT 1.15; 95% CI: 1.06–
1.25, and for TST aOR: 1.10; 95% CI 1.01–1.20). HIV positivity was less common among those with positive results on QFT-GIT
(aOR: 0.51; 95% CI: 0.39–0.67) and TST (aOR: 0.61; 95% CI: 0.46–0.82). Smear positivity of the index case was associated with
QFT-GIT (aOR: 1.25; 95% CI: 0.90–1.74) and TST (aOR: 1.39; 95% CI: 0.98–1.98) results. We found little evidence in our data to
support our hypotheses.
Conclusion: QFT-GIT may not be more sensitive than the TST to detect risk factors associated with tuberculous infection. We
found little evidence to support the hypotheses that positivity in QFT-GIT is more related to recent infection and less
affected by HIV than the TST.
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Introduction
Tuberculosis continues to be a major public health problem in
sub-Sahara Africa. The incidence of tuberculosis [1] is being
accelerated by high rates of HIV co-infection [2,3]. Targeted
testing and treatment of latent tuberculosis infection (LTBI)
especially among HIV positive individuals is an important strategy
to reduce the incidence of tuberculosis [4].
Currently, LTBI detection relies on the tuberculin skin test
(TST) in most countries with high incidence of tuberculosis
although this is not routinely performed and is perceived as a
barrier to accessing TB preventive therapy [5]. However, TST has
many reported limitations. These include low specificity in
populations with high levels of BCG vaccination or significant
exposure to non-tuberculosis mycobacteria (NTM), and reduced
sensitivity in immunocompromised individuals such as those with
HIV infection [6,7].
T-cell based interferon-gamma release assays (IGRAs) such as
the QuantiFERON-TB Gold In-Tube (QFT-GIT) can now also
be used to detect LTBI [8]. IGRAs are in-vitro blood tests based
on interferon-c release after T-cell stimulation by antigens more
specific to Mycobacterium tuberculosis (Mtb) than the purified protein
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derivative used in TST. IGRAs are therefore designed to have
high specificity that is unaffected by BCG vaccination and cross-
reactivity with most NTM [8]. There is also some evidence of
greater sensitivity among HIV positive individuals [9,10] com-
pared to the TST. Current literature suggests that IGRAs detect
responses of effector T-cells that have recently encountered
antigens in vivo, while TST reflects the mobilization of a wider
spectrum of memory T-cells that are long-lived [11].
The use of IGRAs in developed countries is rapidly expanding
but their performance in settings with a high prevalence of
tuberculosis and HIV still requires further research [12,13]. There
is growing evidence that IGRAs performance varies in different
settings [14]. In high-TB burden settings, the results of IGRAs
may be influenced by factors that affect the immune response [15]
such as HIV co-infection, BCG vaccination, malnutrition, tropical
infections and widespread exposure to NTM. Recent studies done
in low and middle income settings [16] showed a large reduction
in the proportion of positive test results for both QFT-GIT and
TSPOT in HIV infected individuals. Another recent study in
Bangladesh showed that malnutrition and helminth infections
were associated with indeterminate QFT-GIT results in children
[17].
Significant challenges exist in directly assessing whether IGRAs
are superior to TST in diagnosing LTBI as there remains no gold
Figure 1. Flow diagram of study participants. QFT-GIT (QuantiFERON-TB Gold In Tube) not done was due to refusal (18.4%), being absent
(18.3%), insufficient blood samples (0.4%) or missing data (1.6%). TST (Tuberculin skin test) not done was due to refusal (5.6%), not returning for
reading (3.6%) or missing data (0.8%). Individuals with QFT-GIT/TST not done and those with indeterminate QFT-GIT results were excluded from
analysis.
doi:10.1371/journal.pone.0018206.g001
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standard against which to compare either test. In the absence of a
practical gold standard for Mtb infection, exposure to an infectious
TB index case has been used as a surrogate measure of infection
[18,19,20,21]. Studies from low-TB burden countries indicate that
the IGRAs correlate better, along a gradient of exposure, than the
TST [14]. Nevertheless, in high-TB burden settings, the TST
performs reasonably well and correlates as well, or better, with
proxy measures of exposure [14]. There are limited data on the
comparison of QFT-GIT and TST in relation to Mtb exposure as
a surrogate measure of infection and the influence of age [19].
In this study, we describe the prevalence of tuberculous
infection among household contacts of recently diagnosed
tuberculosis patients as measured by QFT-GIT and TST in 24
communities with a high prevalence of TB and HIV in Zambia
and South Africa. We also determine risk factors associated with
positive QFT-GIT and TST results and the level of agreement
between the tests in each community. We use data from two recent
TST surveys [22] to explore the correlation between community
TB transmission and infection prevalence in contacts as measured
by QFT-GIT and TST. A TST survey, if conducted correctly and
technically interpretable, allows an estimation of the extent of Mtb
transmission that has occurred in the community [23].
Finally, we formally assess the extent to which our results are
compatible with expected findings on the basis of a number of prior
hypotheses about the characteristics of each test. Previous studies
have given rise to prevailing views about the expected performance of
both TST and IGRAs [7,11,14,16]. We therefore explore whether
our data support the hypotheses that positivity in QFT-GIT is more
related to recent infection and less affected by HIV than the TST.
Methods
Ethics statement
Ethics approval for the study was obtained from the research
ethics committees of the University of Zambia, the London School
of Hygiene and Tropical Medicine and Stellenbosch University. All
individuals involved in the study gave written informed consent.
Study setting
This cross-sectional study was nested within a large community
randomized trial of interventions to reduce tuberculosis transmis-
sion, the Zambia South Africa TB and AIDS Reduction Study,
(ZAMSTAR) in 24 selected communities in Zambia and South
Africa [24]. We defined a ‘‘community’’ as the population
(minimum size of 25,000) accessing one tuberculosis diagnostic
centre and this was the unit of randomization for the ZAMSTAR
trial. The communities selected were in five provinces of Zambia
(16 communities) and in Western Cape Province of South Africa (8
communities) and included both urban and rural communities.
The design of the ZAMSTAR study is described elsewhere
[24,25].
Baseline measurement of tuberculous infection in all ZAM-
STAR communities was estimated by means of TST surveys
among primary school children [22]. These community-wide
surveys served three objectives: to characterize ZAMSTAR
communities, with regards to TB infection, in relative terms; to
inform the randomization of the communities into intervention
arms; and to provide data for one of ZAMSTAR’s secondary
outcomes.
Zambia and South Africa have among the highest tuberculosis
incidence [26] and HIV seroprevalence rates [27] in Africa and
globally. The estimated HIV prevalence in new tuberculosis cases
is 70% [26].
Participants
From April 2007 to July 2008 we recruited newly notified adult
tuberculosis cases from the 24 ZAMSTAR communities, subse-
Table 1. Characteristics of the study population.
Study participants n (column %)
Total 2220
Sex
Male 666 (30.1)
Female 1545 (69.9)
Missing 9
Age group (years)
15–24 835 (38.3)
25–34 556 (25.5)
35–44 302 (13.9)
45–54 246 (11.3)
55–64 134 (6.1)
.65 106 (4.9)
Missing 41
Age in years: Median 28 (IQR:21–42);
mean 33
Highest level of education
Not attended school 142 (6.5)
Primary school 689 (31.9)
Secondary school 1126 (52.1)
College or University 203 (9.4)
Missing 60
Smoking habits
Daily smoker 220 (10.0)
Occasional smoker 73 (3.3)
Ex-smoker 104 (4.7)
Never smoked 1801 (81.9)
Missing 22
1Alcohol consumption
No 1648 (75.2)
Yes 544 (24.8)
Missing 28
Household size (adults)
1–3 331 (15.0)
4–6 848 (38.4)
7–9 554 (25.1)
$10 477 (21.6)
Missing 10
HIV status
Negative 1271 (62.4)
Positive 765 (37.6)
Missing 184
Smear status of index
Smear negative 741 (49.2)
Smear positive 766 (50.8)
Missing 713
1Defined as alcohol consumption four weeks prior to the interview.
doi:10.1371/journal.pone.0018206.t001
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Table 2. TB infection prevalence estimates and Cohen’s kappa coefficients per community.
Community code Geography Urban/rural 1HIV prevalence
Number with
both TST &
QFT results
QFT-GIT
positive (%)
TST positive
(10 mm) (%) Kappa
SA1 Province Urban Moderate 109 78 42 0.17
SA 3 Metropole Urban High 98 77 77 0.49
SA 6 Province Rural Moderate 70 77 27 0.15
Z 4 Lusaka Urban High 69 72 41 0.25
SA 5 Metropole Urban Moderate 52 71 62 0.28
Z 5 Copperbelt Urban High 45 71 13 20.09
SA 2 Province Rural Moderate 87 70 28 0.16
SA 4 Metropole Urban High 140 68 61 0.18
Z1 Lusaka Urban High 93 67 49 0.36
Z 15 Luapula Rural Moderate 24 67 33 0.25
SA 7 Metropole Urban High 74 66 76 0.38
Z 11 Luapula Rural Moderate 40 65 73 0.02
SA 8 Metropole Urban High 124 65 24 20.01
Z 7 Lusaka Urban High 92 61 38 0.19
Z 6 Lusaka Urban High 84 61 61 0.48
Z 8 Southern Urban High 121 60 42 0.41
Z 3 Copperbelt Urban High 48 60 17 0.16
Z 10 Central Urban High 68 59 34 0.08
Z 12 Copperbelt Urban High 97 59 15 0.19
Z 13 Central Urban High 103 50 23 0.16
Z 2 Copperbelt Urban High 90 48 28 0.32
Z 16 Southern Rural Moderate 18 44 17 0.16
Z 9 Southern Urban High 29 38 7 0.22
Z 14 Southern Rural Moderate 28 29 11 0.25
Communities arranged from highest to lowest TB infection prevalence estimates as defined by Quantiferon-TB Gold In-Tube (QFT-GIT) test. SA: South African
community; Z: Zambian community; TST (Tuberculin skin test). Geography, urban/rural and HIV prevalence as described elsewhere [22,25].
1A panel of eight experts critically examined data from ante-natal clinic surveillance, prevention of mother-to-child transmission programmes, voluntary counseling and
testing clinics and provincial demographic and health survey data and made an informed decision whether to categorize HIV prevalence as ‘high’ or ‘moderate’ for
each community [25].
doi:10.1371/journal.pone.0018206.t002
Figure 2. Scatter plot of positive QFT-GIT results in contacts and infection prevalence results from previous TST surveys. Previous
TST surveys among children were conducted within the same communities as those of contacts. Infection prevalence in children was defined as TST
$10 mm.
doi:10.1371/journal.pone.0018206.g002
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quently referred to as index cases, to the study. All tuberculosis
cases (pulmonary smear positive, smear negative or extrapulmo-
nary) were eligible if recruited within a month after being notified
in the tuberculosis register and started on treatment at a
government clinic. We obtained written informed consent from
those accepting to take part in the study. In addition, we sought
permission from these index cases to visit their households where
we invited household members to participate. We made at least
three attempts to visit household members who were absent during
the first visit to the household.
We defined household contacts as individuals at least 15 years
old, who generally slept in the home, ate with the index case and
who identified a common household head. We asked all household
contacts for individual signed consent before participating in the
study. This study focuses on this population of household contacts
of newly diagnosed tuberculosis cases.
Measures
Consenting household contacts had blood drawn for HIV
antibodies and QFT-GIT testing. Tuberculin skin tests were also
performed. A standardized questionnaire was administered to all
contacts by trained interviewers, who collected information on risk
factors associated with tuberculous infection. Sputum microscopy
for index cases was performed as part of the clinic routine services
and the results were recorded in the TB registers.
HIV testing was done using the Abbot Murex HIV Ag/Ab
combination ELISA (Murex Biotech, Dartford, United Kingdom).
All individuals were encouraged to attend counseling and HIV
testing at the local health centre. In South Africa, HIV positive
individuals were advised to go for TB preventive therapy in
accordance with National Tuberculosis Control Program guide-
lines [28] while in Zambia this is not yet government policy.
However, in Zambia, preventive therapy was offered to eligible
contacts through collaboration with another study operating in the
ZAMSTAR sites.
QFT-GIT procedure. QFT-GIT test was performed
according to the manufacturer’s instructions [29]. For four
Zambian and all the South African communities, QFT-GIT
processing was done centrally at our research laboratories in
Lusaka and Stellenbosch University Medical School respectively.
However, for twelve Zambian remote communities, QFT-GIT
processing was decentralized. In these communities, blood samples
were collected, incubated, separated and stored locally. Tubes
were incubated for 16–24 hours at 37uC and plasma was
harvested and frozen at –20uC. Frozen samples from these sites
were transported monthly to the central laboratory in Lusaka
where the ELISA was performed manually in batches.
TST procedure. The skin testing was conducted using 2 TU
(Tuberculin Units) of PPD RT23 with Tween, supplied by the
Statens Serum Institut (Copenhagen, Denmark). All tests were
administered and read by nurses who were trained according to
the standard IUATLD protocol [23]. A dose of 0.1 ml was
injected intradermally on the left forearm. Skin reactions were
read using calipers 72 hours later. A positive TST was defined as
an induration of $10 mm. Blood for QFT-GIT was drawn before
TST was administered usually on the same day.
Statistical analysis
Data were double entered into a ‘‘Microsoft SQL Server’’
database and checked for errors. Analysis was performed using
STATA (version 11.0).
The characteristics of the study population were described using
frequencies and percentages for categorical variables and the
median and interquartile range for quantitative variables. Prevalence
of infection was defined as the number of QFT-GIT or TST positive
results divided by the total number of individuals with interpret-
able (positive and negative) results. Individuals having missing
TST or indeterminate QFT-GIT results were excluded from the
analysis. These did not differ significantly from those that had
interpretable results (results not shown). Furthermore, household
contacts on TB treatment were excluded from analysis.
The level of agreement between test results was assessed for
each community using Cohen’s kappa coefficient. By convention,
kappa values of less than 0.4 generally indicate poor agreement.
Correlation between continuous interferon-c values (IU/ml) and
TST induration (mm) was assessed using Spearman’s correlation
coefficient for each community.
Figure 3. Scatter plot of positive TST results in contacts and infection prevalence results from previous TST surveys. Previous TST
surveys among children were conducted within the same communities as those of contacts. Infection prevalence in contacts and children was
defined as TST $10 mm.
doi:10.1371/journal.pone.0018206.g003
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Table 3. Univariable and multivariable odds ratios showing risk factors associated with positive QuantiFERON-TB Gold In Tube
assay results.
QFT positive
n (row %) Crude OR (95% CI) Adjusted OR (95% CI)
1
Total 1147/1803 (63.6%)
Sex
Male 333(63.5) 1 1
Female 809 (63.7) 1.08 (0.76–1.25) 0.93 (0.72–1.20)
Missing 5
Age group (years)
15–24 417 (60.8) 1 1
25–34 276 (61.3) 1.00 (0.74–1.34) 1.00 (0.74–1.34)
35–44 159 (66.5) 1.35 (0.93–1.96) 1.34 (0.92–1.94)
45–54 139 (68.5) 1.49 (1.0–2.22) 1.47 (0.98–2.20)
55–64 87 (75.6) 2.46 (1.43– 4.23) 2.56 (1.47–4.48)
.65 53 (64.6) 1.42 (0.79– 2.53) 1.46 (0.79–2.70)
Missing 16
Highest level of education
Not attended school 75 (64.7) 1 1
Primary school 378 (67.1) 1.11 (0.68—1.81) 1.4 0 (0.82–2.38)
Secondary school 551 (60.9) 0.79 (0.49–1.28) 0.99 (0.57–1.71)
College or University 111 (67.3) 1.12 (0.62–2.02) 1.40 (0.73–2.69)
Missing 32
Smoking habits
Never smoked 913 (62.7) 1 1
Ex-smoker 42 (53.9) 0.73 (0.43–1.24) 0.60 (0.34–1.07)
Occasional smoker 43 (70.5) 1.40 (0.73–2.66) 1.13 (0.57–2.25)
Daily smoker 137 (72.9) 1.69 (1.14–2.50) 1.14(0.73–1.77)
Missing 12
Alcohol consumption
No 844 (62.9) 1 1
Yes 285 (65.4) 1.11 (0.85–1.45) 1.04 (0.78–1.38)
Missing 18
Household size (adults)
1–3 170 (61.8) 1 1
4–6 415 (62.7) 1.03 (0.73–1.46) 1.30 (0.90–1.87)
7–9 302 (64.4) 1.14 (0.78– 1.67) 1.46 (0.97–2.19)
$10 258 (65.3) 1.16 (0.77–1.75) 1.68(1.09–2.61)
Missing 2
HIV status
Negative 728 (69.0) 1 1
Positive 335 (54.6) 0.48 (0.37–0.61) 0.51 (0.39–0.67)
Missing 84
Smear status of index
Smear negative 373 (60.8) 1 1
Smear positive 426 (67.6) 1.48 (1.09– 2.01) 1.25 (0.90–1.74)
Missing 348
Sleeping proximity to index
Different house 72(57.6) 1 1
Same house 355 (63.6) 1.31 (0.78–2.18) 1.07 (0.61–1.86)
Same room 36 (56.3) 0.92 (0.42–2.02) 1.19 (0.52–2.72)
Risk Factors Associated with Tuberculous Infection
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The distribution of positive reactions to each test in relation to
established individual and household level risk factors for LTBI was
described. The strength of relationship between risk factors and
QFT-GIT/TST positivity was assessed using random effects logistic
regression. The random effects approach specified the household of
residence as the clustering variable. All models were adjusted for
age, sex and community of residence. We present adjusted odds
ratios (ORs) and 95% confidence intervals (CIs) for each risk factor.
Finally, we formally assessed four hypotheses related to the
expected performance of the tests. We explored whether our data
were compatible with expected findings on the basis of a number of
prior hypotheses about the characteristics of each test. Ideally, we
would have had a gold standard measure of LTBI against which to
compare both tests. However, no such test currently exists.
Furthermore, the natural history of LTBI remains a source of debate
[11] and as in other studies of LTBI we had no direct measure of
exposure to Mtb either recently or in the past. However, we did have
data on three proxies related to prior exposure to Mtb (age) or recent
exposure to Mtb (proximity to and infectivity of the index case).
Thus, we tested: (i) whether HIV infection was associated with a
negative TST result, among those with a positive QFT-GIT, since
we expect HIV infection to cause more false negative results with
TST than QFT-GIT. We restricted the analysis to individuals with
a positive QFT-GIT result and used random effects logistic
regression models as described previously.
We then explored: (ii) whether age was more strongly associated
with a positive TST result than with a positive QFT-GIT result since
we expected TST to be more likely to detect evidence of lifetime
infection with Mtb while QFT-GIT was more likely to detect recent
infections; (iii) whether living with a smear positive index case was more
strongly associated with a positive QFT-GIT result than a positive
TST result, since we expected that QFT-GIT would be more strongly
associated with recent infections than TST; and (iv), for the same
reason as (iii), whether sleeping in the same room as the index case was
more strongly associated with QFT-GIT than TST positivity.
For these final three hypotheses we conducted matched-pairs
analysis using conditional logistic regression in an approach similar
to that used by Ewer and others (21), where the outcome is the
result of the TST or QFT-GIT test. We used Wald tests to assess
the strength of evidence for an interaction between the test used
and the factor of interest (age, living with a smear positive index
case, sleeping in same room as index case). In these models we
specified the individual identifier to indicate the paired data, and
calculated confidence intervals using robust standard errors taking
account of household level clustering.
Results
Figure 1 shows the flow chart of the study participants. A total of
2220 contacts were recruited across the 24 communities. As shown
in table 1, the study population was predominantly women
(69.9%), most had attended secondary education (52.1%) and had
no history of smoking (81.9%) or alcohol consumption (75.2%).
765/2036 (37.6%) of household contacts were HIV positive, and
766/1507 (50.8%) lived with a smear positive TB index case.
A total of 1803 individuals had interpretable results available for
both QFT-GIT and TST (figure 1). Of these, 1147 (63.6%) tested
positive with QFT-GIT while 725 (40.2%) tested positive with
TST (figure 1). In all but two communities infection prevalence as
measured by QFT-GIT was higher than that of TST (table 2).
Overall, infection prevalence as measured by TST was higher for
South African communities (arithmetic mean 50%, range 24–
77%) than for the Zambian communities (arithmetic mean 31%,
range 7–73%). Results were similar for QFT-GIT (results not
shown).
There were 577 (32%) individuals with concordant positive
results and 508 (28.2%) had concordant negative results. QFT+/
TST2 discordant results were more common than QFT2/TST+
results (31.6% vs 8.2%). There was a low level of agreement overall
in the 24 communities (% agreement= 60.2%; kappa= 0.24
(arithmetic mean 0.23, range 20.09–0.49)), and in each of the
communities (range of kappas: 0–0.49) (table 2). Using different cut-
off values for the TST did not improve overall test agreement in the
24 communities (kappa: 0.26, 0.24 and 0.14 for TST cutoffs of 5, 10
and 15 mm respectively). When results were stratified by HIV
status, agreement appeared slightly better in HIV positive (%
agreement = 65.1%; kappa 0.322) compared to HIV negative (%
agreement= 57.4%; kappa 0.19) contacts. There was a positive
correlation (correlation coefficient square, r2 = 0.372) between
positive QFT-GIT results in contacts and infection prevalence
results in children (figures 2), however, this was weaker for the TST
(correlation coefficient square, r2 = 0.155) (figure 3).
Tables 3 and 4 show risk factors associated with positive QFT-
GIT and TST results respectively. Both QFT-GIT and TST
results were associated with increasing age (adjusted OR [aOR]
for each 10 year increase for QFT-GIT 1.15; 95% CI: 1.06–1.25;
p,0.001 for linear trend, and for TST aOR: 1.10; 95% CI 1.01–
1.20; p = 0.025 for linear trend). HIV positivity was less common
among those with positive results on QFT-GIT (aOR: 0.51; 95%
CI: 0.39–0.67; p,0.001) and TST (aOR: 0.61; 95% CI: 0.46–
0.82; p = 0.001).
There was some evidence of an association between smear
positivity of the index and QFT-GIT (aOR: 1.25; 95% CI: 0.90–
1.74) and TST (aOR: 1.39; 95% CI: 0.98–1.98) results.
Both QFT-GIT (aOR for household size: 1.04; 95% CI: 1.00–
1.09, p = 0.65 for linear trend) and TST (aOR: 0.97; 95% CI:
0.93–1.01, p = 0.005 for linear trend) results were not associated
with increasing household size.
Finally, we tested the four specific hypotheses described in the
methods. As shown in table 5, we found little evidence to support
the hypotheses that positivity in QFT-GIT is more related to
recent infection and less affected by HIV than the TST.
QFT positive
n (row %) Crude OR (95% CI) Adjusted OR (95% CI)
1
Same bed 142 (62.3) 1.26 (0.71–2.23) 1.16 (0.62–2.14)
Unknown 221 (63.1) 1.26 (0.73–2.16) 1.10(0.61–1.99)
Missing 321
1Odds ratios-adjusted for sex, age and community using random effects logistic regression.
doi:10.1371/journal.pone.0018206.t003
Table 3. Cont.
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Table 4. Univariable and multivariable odds ratios showing risk factors associated with positive tuberculin skin test results.
TST $10 mm
n (row %) Crude OR (95% CI)
1Adjusted OR (95% CI)
Total 725/1803 (40.2%)
Sex
Male 203 (38.7) 1 1
Female 520 (40.9) 1.22 (0.92–1.62) 1.18 (0.90 – 1.56)
Missing 2
Age group (years)
15–24 263 (38.4) 1 1
25–34 177 (39.3) 1.10 (0.79–1.54) 1.05 (0.77–1.45)
35–44 102 (42.7) 1.41 (0.93–2.13) 1.49 (1.00–2.21)
45–54 88 (43.3) 1.34(0.87–2.07) 1.34 (0.89–2.04)
55–64 58 (50.4) 2.01(1.17–3.47) 2.03 (1.19–3.45)
.65 28 (34.1) 1.05(0.55–2.00) 1.12 (0.58–2.17)
Missing 9
Highest level of education
Not attended school 39 (33.6) 1 1
Primary school 236 (41.9) 1.47 (0.85–2.55) 1.53 (0.88–2.66)
Secondary school 365 (40.3) 1.22 (0.72–2.10) 1.29 (0.72–2.31)
College or University 74 (44.8) 1.49 (0.77–2.90) 1.13 (0.57–2.25)
Missing 11
Smoking habits
Never smoked 573 (39.3) 1 1
Ex-smoker 32 (41.0) 1.19 (0.64–2.20) 1.09 (0.59–2.02)
Occasional smoker 31 (50.8) 1.51 (0.75–3.02) 1.26 (0.63—2.54)
Daily smoker 85 (45.2) 1.33 (0.87–2.02) 1.10 (0.70–1.73)
Missing 4
Alcohol consumption
No 544 (40.6) 1 1
Yes 174 (39.9) 0.93 (0.68–1.27) 0.94 (0.69–1.28)
Missing 7
Household size (adults)
1–3 127 (46.2) 1 1
4–6 261 (39.4) 0.68 (0.44–1.03) 0.77 (0.52–1.13)
7–9 192 (40.9) 0.72 (0.46–1.14) 0.91 (0.59–1.40)
$10 144 (36.5) 0.57 (0.35–0.94) 0.71 (0.44–1.13)
Missing 1
HIV status
Negative 465 (44.1) 1 1
Positive 207 (33.8) 0.57 (0.43–0.76) 0.61 (0.46 – 0.82)
Missing 53
Smear status of index
Smear negative 230 (37.5) 1 1
Smear positive 290 (46.0) 1.65 (1.15–2.36) 1.39 (0.98 – 1.98)
Missing 205
Sleeping proximity to index
Different house 43 (34.4) 1 1
Same house 202 (36.2) 1.08 (0.62–1.89) 0.76 (0.44–1.30)
Same room 20 (31.2) 0.80 (0.34–1.92) 0.94 (0.41–2.15)
Same bed 91 (39.9) 1.37(0.74–2.55) 0.80 (0.44–1.46)
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Discussion
We conducted a large scale evaluation of the prevalence of
LTBI as detected by TST and QFT-GIT among household
contacts of tuberculosis patients in 24 high HIV and TB
prevalence communities in Zambia and South Africa. Our
findings suggest a high prevalence of LTBI among this population.
QFT-GIT estimates were higher than those of TST in all but two
communities. LTBI prevalence was higher in South African
communities compared to the Zambian ones, as in previous
findings [22].
LTBI was more common among older individuals and those
who were HIV negative, similar to previous studies in this setting
[9,10,30]. HIV positivity was less common among those with
positive results on QFT-GIT and TST. We found little evidence to
support the hypothesis that HIV infection was associated with
TST negativity among QFT-GIT positive individuals as would
have been expected if HIV causes more false negatives with TST
than QFT-GIT. Both TST and QFT-GIT are prone to false
negatives results among different population groups [9,30]. In a
study done in Zambia, low CD4+ counts in HIV positive TB
patients were associated with increases in both indeterminate and
false-negative QFT-GIT results [9]. Current evidence suggests
that IGRAs perform similarly to the TST at identifying HIV-
infected individuals with LTBI [16].
For both QFT-GIT and TST, prevalence of infection was
higher in contacts exposed to smear positive index cases compared
to smear negative ones, consistent with findings of other studies
[31]. Sleeping proximity of the contact to the index case was not
associated with either QFT-GIT or TST results. In contrast, a
study done in Cape town found an association between Mtb
contact scores and increasing exposure [19], simliar to findings in
the Gambia [21]. Both of these studies had smaller sample sizes
compared to our study and were done among HIV negative [19]
or few HIV postive contacts [21]. There is growing evidence
suggesting a stronger and better defined association between
surrogate markers for TB exposure and QFT-GIT results in low
TB incidence settings compared to high-TB incidence settings
[14,32,33,34] although this is still inconclusive.
Our results suggest that tuberculous infection in adults may
often be unrelated to household transmission. It is well recognized
that transmission of tuberculosis in high incidence settings occurs
not only within households but in the community as well [35,36]
among various social locations [37]. A study in Zimbabwe found
that the proportion of ELISpot positive contacts was not different
from community controls [31]. In another study done in two
communities in Zambia, almost 50% of community controls were
QFT-GIT positive [38]. In our study, positive QFT-GIT results in
contacts correlated well with infection prevalence results from
previous TST surveys, providing further evidence that community
transmission seems to play a bigger role in positivity than
household exposure. However, in a large study in Colombia,
IFN-c responses to CFP-10 were consistently higher in household
contacts of all ages compared to subjects in the source population
[34]. Nevertheless, a seven day whole blood culture in-house assay
was used, which primarily detects central memory responses. It has
been argued that, in settings of high endemicity where a mixture of
recent and old infections are commonly found, long term assays
are more sensitive than those with shorter culture times [34].
We found little evidence in our matched pair analysis to support
the idea that age was more strongly associated with a positive TST
result than with a positive QFT-GIT result since we anticipated
that TST was more likely to detect evidence of lifetime infection
with Mtb while QFT-GIT was more likely to detect recent
infections. Our results using conditional logistic regression showed
that age was associated with positive QFT-GIT and TST results
and there was a trend to increased responses with increasing age
for both tests suggesting cumulative exposure to Mtb. In the study
done in Colombia [34], exploration of IFN-c variations by age
revealed a trend to increased responses up to adulthood with CFP,
but not with CFP-10, similar to observations in Uganda [39].
However, children were included in both of these studies.
We show a low level of agreement between the tests in all
communities, consistent with findings of studies done in high-TB
burden settings [19,31,40]. As IGRAs are designed to be more
specific than TST, perfect agreement is not expected [41].
However, better agreement has been shown when the comparison
is done within specific risk groups like HIV positives [42].
Although kappa statistics have been widely used as a measure of
agreement between IGRAs and TST, alternative statistical
approaches have recently been proposed such as latent class
analysis [43] but have yet to gain wider acceptance. Similar to
other studies reported from poor-resource settings [44], there were
particularly high number of QFT-GIT+/TST- discordant results,
in contrast to studies done in settings with low TB incidence
[45,46] where TST+/QFT-GIT- discordance is more common.
Our study had both strengths and limitations. Ours is among
the first studies to conduct both TST and QFT-GIT tests using a
large sample size which illustrates the realistic implementation of
QFT-GIT in a setting with a high burden of TB and HIV.
However, as for all studies of this nature we had no gold standard
measure of LTBI against which to compare our tests. As such, we
were unable to comment directly on the accuracy of either test, but
rather to compare the findings of each test in relation to prior
beliefs about their properties. It is plausible that our failure to
prove our hypotheses may have been due to test limitations typical
in such high-TB burden settings. In addition, individuals in these
settings may have mixed infections due to multiple Mtb exposure.
Our results may have been severely compromised by missing
data on some risk factors. Despite efforts to standardize TST
training and reading across the two countries, use of different
teams may have contributed to inter-reader variability. Although
most contacts reported that they had never smoked or taken
alcohol, we believe this was due to reporting bias. We had no data
TST $10 mm
n (row %) Crude OR (95% CI)
1Adjusted OR (95% CI)
Unknown 128 (36.6) 1.11 (0.61–2.00) 0.74 (0.41–1.33)
Missing 241
1Odds ratios-adjusted for sex, age and community using random effects logistic regression.
doi:10.1371/journal.pone.0018206.t004
Table 4. Cont.
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on likely exposure to NTM which may provide an alternative
reason for false positive results, especially with TST.
Probably the most important characteristic of tests of LTBI is
the extent to which they predict subsequent clinical tuberculosis.
The data we present here are cross-sectional in nature; however,
they come from a larger longitudinal study whose participants
have been followed up for later development of active TB.
Conclusion
QFT-GIT may not be more sensitive than the TST to detect
risk factors associated with tuberculous infection. Given the lack of
strong associations with either TST or QFT-GIT with risk factors
generally accepted to be related to household infectivity, these
results suggest that tuberculous infection in adults in these
communities may often be unrelated to household transmission.
We found little evidence to support the hypotheses that positivity
in QFT-GIT is more related to recent infection and less affected
by HIV than the TST.
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